Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: A stretchable device is provided including a base layer; a wipe layer attached to the base layer at a seam and defining an interior space between the wipe and base layers, the interior space having an internal surface; and a pouch positioned within the interior space and attached to one of the seam and the internal surface, the pouch having a top layer, a bottom layer attached to the top layer to form a cavity therebetween, an opening in one of the top and bottom layers, and a pull tab coupled to the pouch and to one of the seam and the internal surface.

Abstract: A flexible and conformable cleaning tool is disclosed that includes a foam body with a first working surface, wherein the foam body has a shore hardness less than 40. The cleaning tool further comprises a cleaning material on at least a portion of the first working surface, wherein the cleaning material includes an array of 20 to 1000 upstanding stems per square centimeter, wherein each stem has a height from 0.2 and 2.0 millimeters and a shore hardness less than 105 A, wherein the cleaning material is wiped over a surface to be cleaned to gather debris, lint, or hair.

Abstract: A leg wrap is adapted to wrap around a limb of a person. The wrap includes an elongated flexible body having a first end and a second end opposite the first end along a length of the flexible body. A first fastener is positioned on the flexible body proximate the second end of the flexible body and is adapted to fasten to the flexible body. A flap is positioned between the first end and the second end of the flexible body. The flap has a first end secured to the flexible body and a second end being moveable with respect to the second body. The second fastener is positioned on a flap and adapted to fasten to the flexible body.

Abstract: A stretchable device is provided including a base layer; a wipe layer attached to the base layer at a seam and defining an interior space between the wipe and base layers, the interior space having an internal surface; and a pouch positioned within the interior space and attached to one of the seam and the internal surface, the pouch having a top layer, a bottom layer attached to the top layer to form a cavity therebetween, an opening in one of the top and bottom layers, and a pull tab coupled to the pouch and to one of the seam and the internal surface.

Abstract: A disposable face mask includes a mask body covering substantially a nose, mouth, and chin of a wearer, and an extension provided with the mask body. The extension is configured to encircle a back of a wearer's head and to substantially cover a wearer's cheeks, jaw, and ears. A substantial portion of the extension is formed from a resilient material treated with a repellant agent to prevent contaminants from entering or exiting such treated portion of the extension.

Abstract: A disposable face mask includes a mask body covering substantially a nose, mouth, and chin of a wearer, and an extension provided with the mask body. The extension is configured to encircle a back of a wearer's head and to substantially cover a wearer's cheeks, jaw, and ears. A substantial portion of the extension is formed from a resilient material treated with a repellant agent to prevent contaminants from entering or exiting such treated portion of the extension.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: A method of producing a plurality of face masks is provided. The method includes the step of providing a continuous web that is of the same material throughout. A plurality of body portions are stamped from the continuous web so that each of the plurality of face masks has one body portion. A plurality of left extension portions are stamped from the continuous web so that each of the body portions has one left extension portion integrally attached thereto. A plurality of right extension portions are stamped from the continuous web so that each of the body portions has one right extension portion integrally attached thereto. A dispenser assembly for dispensing face masks is also provided. The assembly includes a core and a roll of face masks that are rotatably disposed on the core. As least one of the face masks includes a body portion and left extension portion that is integrally attached to the body portion. A right extension portion is integrally attached to the body portion.

Abstract: A disposable face mask includes a mask body covering substantially a nose, mouth, and chin of a wearer, and an extension provided with the mask body. The extension is configured to encircle a back of a wearer's head and to substantially cover a wearer's cheeks, jaw, and ears. A substantial portion of the extension is formed from a resilient material treated with a repellant agent to prevent contaminants from entering or exiting such treated portion of the extension.

Abstract: The invention relates to a system for dispensing face masks. The system includes a stack of masks arranged within an interior of a container. The container has a dispensing opening therein for the withdrawal of a single or a specific plurality of masks. The ties of the masks within the stack are arranged so that they extend along the interior walls of the container and rest upon the furthest surface of the mask furthest away from the dispensing opening.

Abstract: A disposable face mask includes a mask body covering substantially a nose, mouth, and chin of a wearer, and an extension provided with the mask body. The extension is configured to encircle a back of a wearer's head and to substantially cover a wearer's cheeks, jaw, and ears. A substantial portion of the extension is formed from a resilient material treated with a repellant agent to prevent contaminants from entering or exiting such treated portion of the extension.

Abstract: The invention relates to a system for dispensing face masks. The system includes a stack of masks arranged within an interior of a container. The container has a dispensing opening therein for the withdrawal of a single or a specific plurality of masks. The ties of the masks within the stack are arranged so that they extend along the interior walls of the container and rest upon the furthest surface of the mask furthest away from the dispensing opening.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.